Lv4
424 积分 2025-09-22 加入
Molecular Origin of the Self-Assembly of Lanreotide into Nanotubes: A Mutational Approach
28天前
已关闭
PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery
28天前
已完结
Oral anti-TNF antibody for treatment of Inflammatory Bowel Disease
1个月前
已完结
PEG-PLGA nanoparticles transport across in vitro intestinal epithelial models and show potential for oral delivery of antibodies in inflammatory bowel disease
1个月前
已完结
Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease
1个月前
已完结
Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
1个月前
已完结
Oral delivery of the anti-tumor necrosis factor α domain antibody, V565, results in high intestinal and fecal concentrations with minimal systemic exposure in cynomolgus monkeys
1个月前
已完结
Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients
1个月前
已完结
Oral Gut-Restricted Targeted Therapy for IBD: A Pipeline Review
1个月前
已完结
MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment
1个月前
已完结
皖公网安备34019202002308
